Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Occurrence of pneumonitis following radiotherapy of breast cancer - A prospective study.

Vasiljevic D, Arnold C, Neuman D, Fink K, Popovscaia M, Kvitsaridze I, Nevinny-Stickel M, Glatzer M, Lukas P, Seppi T.

Strahlenther Onkol. 2018 Jun;194(6):520-532. doi: 10.1007/s00066-017-1257-z. Epub 2018 Feb 15.

2.

Sex Differences in Renal Proximal Tubular Cell Homeostasis.

Seppi T, Prajczer S, Dörler MM, Eiter O, Hekl D, Nevinny-Stickel M, Skvortsova I, Gstraunthaler G, Lukas P, Lechner J.

J Am Soc Nephrol. 2016 Oct;27(10):3051-3062. Epub 2016 Apr 28.

3.

Bayesian Cure Rate Modeling of Local Tumor Control: Evaluation in Stereotactic Body Radiation Therapy for Pulmonary Metastases.

Klement RJ, Allgäuer M, Andratschke N, Blanck O, Boda-Heggemann J, Dieckmann K, Duma M, Ernst I, Flentje M, Ganswindt U, Hass P, Henkenberens C, Imhoff D, Kahl HK, Krempien R, Lohaus F, Nestle U, Nevinny-Stickel M, Petersen C, Schmitt V, Semrau S, Sterzing F, Streblow J, Wendt TG, Wittig A, Guckenberger M.

Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):841-9. doi: 10.1016/j.ijrobp.2015.12.004. Epub 2015 Dec 15.

PMID:
26972657
4.

Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy.

Guckenberger M, Klement RJ, Allgäuer M, Andratschke N, Blanck O, Boda-Heggemann J, Dieckmann K, Duma M, Ernst I, Ganswindt U, Hass P, Henkenberens C, Holy R, Imhoff D, Kahl HK, Krempien R, Lohaus F, Nestle U, Nevinny-Stickel M, Petersen C, Semrau S, Streblow J, Wendt TG, Wittig A, Flentje M, Sterzing F.

Radiother Oncol. 2016 Mar;118(3):485-91. doi: 10.1016/j.radonc.2015.09.008. Epub 2015 Sep 15.

PMID:
26385265
5.

Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry.

Kocher F, Hilbe W, Seeber A, Pircher A, Schmid T, Greil R, Auberger J, Nevinny-Stickel M, Sterlacci W, Tzankov A, Jamnig H, Kohler K, Zabernigg A, Frötscher J, Oberaigner W, Fiegl M.

Lung Cancer. 2015 Feb;87(2):193-200. doi: 10.1016/j.lungcan.2014.12.006. Epub 2014 Dec 18.

PMID:
25564398
6.

Stereotactic body radiotherapy for centrally located stage I NSCLC: a multicenter analysis.

Schanne DH, Nestle U, Allgäuer M, Andratschke N, Appold S, Dieckmann U, Ernst I, Ganswindt U, Grosu AL, Holy R, Molls M, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Guckenberger M.

Strahlenther Onkol. 2015 Feb;191(2):125-32. doi: 10.1007/s00066-014-0739-5. Epub 2014 Aug 27.

PMID:
25159135
7.

Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer.

Klement RJ, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N, Guckenberger M.

Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):732-8. doi: 10.1016/j.ijrobp.2013.11.216. Epub 2014 Jan 7.

PMID:
24411630
8.

Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer.

Guckenberger M, Klement RJ, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N, Flentje M.

Radiother Oncol. 2013 Oct;109(1):13-20. doi: 10.1016/j.radonc.2013.09.005. Epub 2013 Oct 30.

PMID:
24183066
9.

Safety and efficacy of stereotactic body radiotherapy for stage 1 non-small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis.

Guckenberger M, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N.

J Thorac Oncol. 2013 Aug;8(8):1050-8. doi: 10.1097/JTO.0b013e318293dc45.

10.

Compensating for tumor motion by a 6-degree-of-freedom treatment couch: is patient tolerance an issue?

Sweeney RA, Arnold W, Steixner E, Nevinny-Stickel M, Lukas P.

Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):168-71. doi: 10.1016/j.ijrobp.2008.07.069. Epub 2009 Jan 23.

PMID:
19167841
11.

Optimized conformal paraaortic lymph node irradiation is not associated with enhanced renal toxicity.

Nevinny-Stickel M, Poljanc K, Forthuber BC, Heute D, Posch A, Lechner J, Beer B, Lukas P, Seppi T.

Strahlenther Onkol. 2007 Jul;183(7):385-91.

PMID:
17609872
12.

Competing irradiation techniques for para-aortic lymph nodes: dose distribution and NTCP for the kidney.

Nevinny-Stickel M, Seppi T, Poljanc K, Forthuber BC, Posch A, Lechner J, Ulmer H, Sweeney R, Saurer M, Lukas P.

Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1206-13. Epub 2005 Jun 22.

PMID:
15978740
13.

Effects of paclitaxel and docetaxel on EGFR-expressing human carcinoma cells under normoxic versus hypoxic conditions in vitro.

Skvortsova I, Skvortsov S, Haidenberger A, Devries A, Nevinny-Stickel M, Saurer M, Lukas P, Seppi T.

J Chemother. 2004 Aug;16(4):372-80.

PMID:
15332713
14.

Reproducibility of patient positioning for fractionated extracranial stereotactic radiotherapy using a double-vacuum technique.

Nevinny-Stickel M, Sweeney RA, Bale RJ, Posch A, Auberger T, Lukas P.

Strahlenther Onkol. 2004 Feb;180(2):117-22.

PMID:
14762665
15.

Conformal proton radiation treatment for retroperitoneal neuroblastoma: introduction of a novel technique.

Hug EB, Nevinny-Stickel M, Fuss M, Miller DW, Schaefer RA, Slater JD.

Med Pediatr Oncol. 2001 Jul;37(1):36-41.

PMID:
11466721
16.

A simple and non-invasive vacuum mouthpiece-based head fixation system for high precision radiotherapy.

Sweeney RA, Bale R, Auberger T, Vogele M, Foerster S, Nevinny-Stickel M, Lukas P.

Strahlenther Onkol. 2001 Jan;177(1):43-7.

PMID:
11200112
17.

Comparison of standard and individually planned infradiaphragmatic fields in irradiation of retroperitoneal lymph nodes.

Nevinny-Stickel M, Ennemoser S, Sweeney R, Bangerl I, Zur Nedden D, Lukas P.

Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):147-51.

PMID:
10924984
18.

Proton radiation therapy (PRT) for pediatric optic pathway gliomas: comparison with 3D planned conventional photons and a standard photon technique.

Fuss M, Hug EB, Schaefer RA, Nevinny-Stickel M, Miller DW, Slater JM, Slater JD.

Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1117-26.

PMID:
10613303
19.

[Standard versus individually planned irradiation field in radiotherapy of infradiaphragmatic lymph node sites].

Nevinny-Stickel M, Ennemoser S, Bangerl I, zur Nedden D, Lukas P.

Strahlenther Onkol. 1998 Jul;174(7):341-4. German.

PMID:
9689953
20.

Repositioning accuracy: comparison of a noninvasive head holder with thermoplastic mask for fractionated radiotherapy and a case report.

Sweeney R, Bale R, Vogele M, Nevinny-Stickel M, Bluhm A, Auer T, Hessenberger G, Lukas P.

Int J Radiat Oncol Biol Phys. 1998 May 1;41(2):475-83.

PMID:
9607367
21.

Clinical value of fructose 1,6 bisphosphatase in monitoring renal proximal tubular injury.

Pfaller W, Thorwartl U, Nevinny-Stickel M, Krall M, Schober M, Joannidis M, Hobisch A.

Kidney Int Suppl. 1994 Nov;47:S68-75.

PMID:
7532742

Supplemental Content

Loading ...
Support Center